TY - JOUR
T1 - CCMG practice guideline: laboratory guidelines for next-generation sequencing
JF - Journal of Medical Genetics
JO - J Med Genet
SP - 792
LP - 800
DO - 10.1136/jmedgenet-2019-106152
VL - 56
IS - 12
AU - Hume, Stacey
AU - Nelson, Tanya N
AU - Speevak, Marsha
AU - McCready, Elizabeth
AU - Agatep, Ron
AU - Feilotter, Harriet
AU - Parboosingh, Jillian
AU - Stavropoulos, Dimitri J
AU - Taylor, Sherryl
AU - Stockley, Tracy L
A2 - ,
Y1 - 2019/12/01
UR - http://jmg.bmj.com/content/56/12/792.abstract
N2 - The purpose of this document is to provide guidance for the use of next-generation sequencing (NGS, also known as massively parallel sequencing or MPS) in Canadian clinical genetic laboratories for detection of genetic variants in genomic DNA and mitochondrial DNA for inherited disorders, as well as somatic variants in tumour DNA for acquired cancers. They are intended for Canadian clinical laboratories engaged in developing, validating and using NGS methods.Methods of statement development The document was drafted by the Canadian College of Medical Geneticists (CCMG) Ad Hoc Working Group on NGS Guidelines to make recommendations relevant to NGS. The statement was circulated for comment to the CCMG Laboratory Practice and Clinical Practice committees, and to the CCMG membership. Following incorporation of feedback, the document was approved by the CCMG Board of Directors.Disclaimer The CCMG is a Canadian organisation responsible for certifying medical geneticists and clinical laboratory geneticists, and for establishing professional and ethical standards for clinical genetics services in Canada. The current CCMG Practice Guidelines were developed as a resource for clinical laboratories in Canada and should not be considered to be inclusive of all information laboratories should consider in the validation and use of NGS for a clinical laboratory service.
ER -